James Morton
Adjunct Professor
University of Southern California
James Morton is an enthusiastic clinical research professional with a blend of clinical operations, clinical development, and stakeholder management experience. His talent lies in building relationships, facilitating collaboration, and curating content to align with clinical strategy. His work includes the design, implementation, oversight, project management, and completion of clinical studies. His specialization led to NDA approvals for three BOTOX indications: glabella lines, hyperhidrosis, and migraine headache. He worked diligently to complete clinical validations of over 50 Laboratory Developed Tests, including Emergency Use Authorization for Quest Diagnostics' COVID-19 At-Home Rapid Antigen Test. He is interested in partnering with others who bring products to market that improve people’s well-being and quality of life. After attending the 2024 conference, he is inspired to investigate programs and projects that are increasing participation in clinical research, recognizing that finding new therapies requires greater participation.